Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 2;13(1):60-63.
doi: 10.4103/idoj.IDOJ_154_21. eCollection 2022 Jan-Feb.

Disease Stability in Segmental and Non-Segmental Vitiligo

Affiliations

Disease Stability in Segmental and Non-Segmental Vitiligo

Neha Taneja et al. Indian Dermatol Online J. .

Abstract

Introduction: Some therapeutic decisions in vitiligo depend on the likelihood of the disease remaining stable and inactive.

Aim: To determine a period of disease stability in vitiligo following which reactivation was unlikely.

Materials and methods: This cross-sectional descriptive study was carried out in 200 patients where a detailed clinical history of the disease activity and stability over the course of vitiligo was recorded.

Results: There were 167 (83.5%) patients with non-segmental vitiligo and 33 (16.5%) with segmental vitiligo. For every 1-year increase in the duration of the disease, stable and active periods increased by 0.7 and 0.3 years, respectively in non-segmental vitiligo and by 0.9 and 0.1 years in segmental vitiligo (P < 0.01). When segmental vitiligo was stable for at least 2 years, it was five times less likely to re-activate than the disease that was stable for less than 2 years (P = 0.16). However, in non-segmental vitiligo, we found no association between the duration of stability and risk of reactivation.

Conclusions: Segmental vitiligo usually becomes inactive after the disease has been stable for 2 years. Non-segmental vitiligo is prone to reactivation even after prolonged periods of stability.

Keywords: Stability; reactivation; vitiligo.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(a and b) Course of disease in patients with non-segmental and segmental vitiligo

References

    1. Moellmann G, Klein-Angerer S, Scollay DA, Nordlund JJ, Lerner AB. Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol. 1982;79:321–30. - PubMed
    1. Falabella R, Escobar C, Borrero I. Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes. J Am Acad Dermatol. 1992;26:230–6. - PubMed
    1. Taneja N, Sreenivas V, Sahni K, Gupta V, Ramam M. A cross-sectional study of spontaneous repigmentation in vitiligo. Indian J Dermatol Venereol Leprol. 2020;86:240–50. - PubMed
    1. Park JH, Jung MY, Lee JH, Yang JM, Lee DY, Park KK. Clinical course of segmental vitiligo: A retrospective study of eighty seven patients. Ann Dermatol. 2014;26:61–5. - PMC - PubMed
    1. Awad SS. Depigmentation during vitiligo activity spares epithelial grafted areas. J Cosmet Dermatol. 2016;15:383–6. - PubMed